TME-SW
01698
XIAOMI-W
01810
TRIP.COM-S
09961
BIDU-SW
09888
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 15.49%4.88B | 26.00%10.42B | 10.12%4.23B | 35.64%8.27B | 39.15%3.84B | 18.91%6.1B | 25.25%2.76B | -34.86%5.13B | -56.13%2.2B | 4.87%7.87B |
Operating income | 15.49%4.88B | 26.00%10.42B | 10.12%4.23B | 35.64%8.27B | 39.15%3.84B | 18.91%6.1B | 25.25%2.76B | -34.86%5.13B | -56.13%2.2B | 4.87%7.87B |
Cost of sales | -10.91%-4.6B | -22.18%-10.16B | -14.35%-4.15B | -40.78%-8.31B | -38.38%-3.63B | -21.06%-5.9B | -26.54%-2.62B | 33.59%-4.88B | 56.41%-2.07B | -11.76%-7.34B |
Operating expenses | -10.91%-4.6B | -22.18%-10.16B | -14.35%-4.15B | -40.78%-8.31B | -38.38%-3.63B | -21.06%-5.9B | -26.54%-2.62B | 33.59%-4.88B | 56.41%-2.07B | -11.76%-7.34B |
Gross profit | 257.95%280.68M | 759.59%266.14M | -62.78%78.41M | -120.80%-40.35M | 53.86%210.7M | -22.87%194.04M | 4.85%136.94M | -52.45%251.57M | -51.21%130.6M | -43.51%529.05M |
Selling expenses | 28.58%-24.78M | -29.15%-95.35M | -48.91%-34.7M | -28.43%-73.83M | -10.15%-23.3M | 22.42%-57.49M | 18.81%-21.15M | 19.68%-74.1M | 62.56%-26.06M | 1.71%-92.26M |
Administrative expenses | -15.08%-133.42M | -37.68%-326.99M | -1.15%-115.94M | 31.56%-237.49M | 41.96%-114.62M | -39.97%-347.03M | -67.32%-197.47M | 19.61%-247.92M | 11.29%-118.02M | 5.88%-308.42M |
Impairment and provision | ---- | -879.22%-28.65M | ---- | ---2.93M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | -879.22%-28.65M | ---- | ---2.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 43.25%81.83M | -22.02%99.53M | 29.37%57.13M | -37.28%127.64M | 146.29%44.16M | 13.02%203.52M | -77.83%17.93M | -19.17%180.07M | -58.68%80.89M | 1,103.52%222.76M |
Operating profit | 1,453.35%204.32M | 62.41%-85.32M | -112.91%-15.1M | -3,160.96%-226.96M | 283.39%116.93M | -106.35%-6.96M | -194.60%-63.76M | -68.78%109.62M | -74.15%67.41M | -34.18%351.13M |
Financing income | 21.88%22.02M | -9.30%53.24M | -41.36%18.07M | -17.75%58.7M | 7.25%30.81M | 16.11%71.37M | -3.35%28.73M | 7.91%61.46M | 3.82%29.72M | -23.42%56.96M |
Financing cost | 17.25%-148.09M | -32.40%-327.73M | -84.24%-178.96M | -43.65%-247.53M | -16.65%-97.13M | -12.91%-172.32M | 1.42%-83.27M | -36.66%-152.61M | -35.12%-84.47M | 33.33%-111.67M |
Share of profits of associates | -152.08%-23.94M | ---- | -31.05%45.96M | ---- | -74.52%66.65M | 69.25%385.3M | 1,679.11%261.6M | 3,136.49%227.65M | 2,888.62%14.7M | 88.61%-7.5M |
Share of profit from joint venture company | 95.85%-11K | ---- | -126.11%-265K | ---- | 693.57%1.02M | 55.18%-16.67M | -108.63%-171K | -222.83%-37.2M | -67.66%1.98M | 137.10%30.28M |
Special items of earning before tax | ---- | 148.85%33.18M | ---- | ---67.92M | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | 141.67%54.3M | 32.47%-326.63M | -210.17%-130.3M | -285.53%-483.71M | -17.36%118.28M | 24.80%260.72M | 387.73%143.12M | -34.55%208.91M | -87.43%29.35M | -17.59%319.21M |
Tax | -215.34%-24.67M | -52.13%-44.62M | 57.83%-7.82M | -314.59%-29.33M | -1,853.59%-18.55M | 52.06%-7.07M | 116.17%1.06M | 80.57%-14.76M | 80.81%-6.54M | 11.15%-75.94M |
After-tax profit from continuing operations | 121.45%29.63M | 27.64%-371.25M | -238.51%-138.12M | -302.27%-513.04M | -30.84%99.72M | 30.64%253.65M | 532.35%144.18M | -20.19%194.16M | -88.57%22.8M | -19.41%243.27M |
Earning after tax | 121.45%29.63M | 27.64%-371.25M | -238.51%-138.12M | -302.27%-513.04M | -30.84%99.72M | 30.64%253.65M | 532.35%144.18M | -20.19%194.16M | -88.57%22.8M | -19.41%243.27M |
Minority profit | -36.58%5.8M | 58.90%119.08M | -32.23%9.14M | 1,486.29%74.94M | 185.16%13.49M | 77.38%-5.41M | -2.78%-15.84M | -640.11%-23.9M | -464.67%-15.41M | -94.22%4.43M |
Profit attributable to shareholders | 116.18%23.83M | 16.61%-490.34M | -270.77%-147.26M | -326.98%-587.98M | -46.11%86.23M | 18.80%259.05M | 318.77%160.02M | -8.70%218.06M | -80.42%38.21M | 6.01%238.84M |
Basic earnings per share | 115.56%0.014 | 16.76%-0.298 | -273.08%-0.09 | -326.58%-0.358 | -46.39%0.052 | 18.80%0.158 | 304.17%0.097 | -8.28%0.133 | -79.83%0.024 | 7.41%0.145 |
Diluted earnings per share | 115.56%0.014 | 16.76%-0.298 | -273.08%-0.09 | -326.58%-0.358 | -46.39%0.052 | 18.80%0.158 | 304.17%0.097 | -8.28%0.133 | -79.83%0.024 | 7.41%0.145 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.